HRP20221439T1 - Proizvod za oralnu njegu - Google Patents
Proizvod za oralnu njegu Download PDFInfo
- Publication number
- HRP20221439T1 HRP20221439T1 HRP20221439TT HRP20221439T HRP20221439T1 HR P20221439 T1 HRP20221439 T1 HR P20221439T1 HR P20221439T T HRP20221439T T HR P20221439TT HR P20221439 T HRP20221439 T HR P20221439T HR P20221439 T1 HRP20221439 T1 HR P20221439T1
- Authority
- HR
- Croatia
- Prior art keywords
- use according
- oral care
- sodium dna
- mouthwash
- weight
- Prior art date
Links
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 22
- 229910052708 sodium Inorganic materials 0.000 claims 22
- 239000011734 sodium Substances 0.000 claims 22
- 239000002324 mouth wash Substances 0.000 claims 13
- 229940051866 mouthwash Drugs 0.000 claims 12
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims 11
- 229960003260 chlorhexidine Drugs 0.000 claims 11
- 230000003239 periodontal effect Effects 0.000 claims 5
- 229940034610 toothpaste Drugs 0.000 claims 5
- 239000000606 toothpaste Substances 0.000 claims 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 4
- 239000004349 Polyvinylpyrrolidone-vinyl acetate copolymer Substances 0.000 claims 2
- 239000003513 alkali Substances 0.000 claims 2
- 150000001342 alkaline earth metals Chemical class 0.000 claims 2
- 229960005070 ascorbic acid Drugs 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- 210000003850 cellular structure Anatomy 0.000 claims 2
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical group [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 235000019448 polyvinylpyrrolidone-vinyl acetate copolymer Nutrition 0.000 claims 2
- 239000004135 Bone phosphate Substances 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 210000003855 cell nucleus Anatomy 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 210000001723 extracellular space Anatomy 0.000 claims 1
- 208000007565 gingivitis Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 210000002200 mouth mucosa Anatomy 0.000 claims 1
- 230000007170 pathology Effects 0.000 claims 1
- 201000001245 periodontitis Diseases 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 1
- 239000001509 sodium citrate Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Jellies, Jams, And Syrups (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (16)
1. Natrijeva DNA za uporabu u postupku za liječenje nuspojava klorheksidina kod pacijenta podvrgnutog liječenju klorheksidinom, pri čemu takve nuspojave uključuju promjenu stanične strukture oralne sluznice navedenog pacijenta, navedena promjena stanične strukture je odabrana u skupini koju čine: vakuolizacija, degeneracija stanične jezgre, širenje međustaničnih prostora.
2. Natrijeva DNA za uporabu prema zahtjevu 1, u kojoj se navedeno liječenje klorheksidinom provodi s proizvodom za oralnu njegu koji sadrži klorheksidin i natrijevu DNA.
3. Natrijeva DNA za uporabu prema zahtjevu 2, naznačena time što navedeni proizvod za oralnu njegu koji sadrži klorheksidin i natrijevu DNA odabran iz skupine koju čine: tekućina za ispiranje usta, parodontalni gel, i pasta za zube.
4. Natrijeva DNA za uporabu prema zahtjevu 3, naznačena time što navedeni proizvod za oralnu njegu je tekućina za ispiranje usta, i količina klorheksidina je u rasponu od 0.01% do 0.30% po težini u odnosu na ukupni volumen tekućine za ispiranje usta.
5. Natrijeva DNA za uporabu prema 3 ili 4, naznačena time što navedeni proizvod za oralnu njegu je tekućina za ispiranje usta i klorheksidin je u obliku soli ili kompleksa.
6. Natrijeva DNA za uporabu prema bilo kojem od zahtjeva 3 do 5, naznačena time što navedeni proizvod za oralnu njegu je tekućina za ispiranje usta i količina natrijeve DNA je u rasponu od 0.01% do 0.2% po težini u odnosu na ukupni volumen tekućine za ispiranje usta.
7. Natrijeva DNA za uporabu prema bilo kojem od zahtjeva 3 do 6, naznačena time što navedeni proizvod za oralnu njegu je tekućina za ispiranje usta koja sadrži najmanje jednu metabisulfitnu sol alkalnog ili zemnoalkalnog metala.
8. Natrijeva DNA za uporabu prema bilo kojem od zahtjeva 3 do 7, naznačena time što navedeni proizvod za oralnu njegu je tekućina za ispiranje usta koja sadrži askorbinsku kiselinu.
9. Natrijeva DNA za uporabu prema bilo kojem od zahtjeva 3 do 8, naznačena time što navedeni proizvod za oralnu njegu je tekućina za ispiranje usta koja sadrži najmanje jedan kopolimer polivinilpirolidon-vinilacetat.
10. Natrijeva DNA za uporabu prema bilo kojem od zahtjeva 3 do 9, naznačena time što navedeni proizvod za oralnu njegu je tekućina za ispiranje usta koja sadrži trobazični natrijev citrat.
11. Natrijeva DNA za uporabu prema bilo kojem od zahtjeva 3 do 10, naznačena time što navedeni proizvod za oralnu njegu je tekućina za ispiranje usta koja sadrži od 0.01% do 0.30% po težini klorheksidina, od 0.01% do 0.2% po težini natrijeve DNA, od 0.1% do 0.5% po težini najmanje jedne metabisulfitne soli alkalijskog ili zemnoalkalijskog metala, od 0.1 % do 1.0% po težini askorbinske kiseline, od 0.05 % do 1% po težini najmanje jednog kopolimera polivinil pirolidon-vinil acetata, u odnosu na ukupni volumen tekućine za ispiranje usta.
12. Natrijeva DNA za uporabu prema zahtjevu 3, naznačena time što navedeni proizvod za oralnu njegu je parodontalni gel koji sadrži od 0.5% do 1.0% po težini klorheksidina, u odnosu na ukupni volumen parodontalnog gela.
13. Natrijeva DNA za uporabu prema 3 ili 12, naznačena time što navedeni proizvod za oralnu njegu je parodontalni gel koji sadrži natrijevu DNA u količini od najviše 0.3% po težini u odnosu na ukupnu težinu parodontalnog gela.
14. Natrijeva DNA za uporabu prema zahtjevu 3, naznačena time što navedeni proizvod za oralnu njegu je pasta za zube koja sadrži od 0.05% do 0.2% po težini klorheksidina, u odnosu na ukupni volumen paste za zube.
15. Natrijeva DNA za uporabu prema zahtjevu 3 ili 14, naznačena time što navedeni proizvod za oralnu njegu je pasta za zube koja sadrži natrijevu DNA u količini od 0.01% do 0.05% po težini u odnosu na ukupni volumen paste za zube.
16. Natrijeva DNA za uporabu je zahtjeva 1 do 15, naznačena time što navedeno liječenje klorheksidinom je za liječenje najmanje jedne patologije odabrane u skupini koju čine: gingivitis, bakterijski plak, i parodontitis.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102019000003009A IT201900003009A1 (it) | 2019-03-01 | 2019-03-01 | Prodotto per l’igiene orale |
| EP20711798.7A EP3930663B1 (en) | 2019-03-01 | 2020-02-27 | Oral care product |
| PCT/EP2020/055199 WO2020178148A1 (en) | 2019-03-01 | 2020-02-27 | Oral care product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20221439T1 true HRP20221439T1 (hr) | 2023-03-03 |
Family
ID=66690786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20221439TT HRP20221439T1 (hr) | 2019-03-01 | 2020-02-27 | Proizvod za oralnu njegu |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20220117868A1 (hr) |
| EP (1) | EP3930663B1 (hr) |
| KR (1) | KR20220004962A (hr) |
| CN (1) | CN113645941A (hr) |
| AR (1) | AR118218A1 (hr) |
| AU (1) | AU2020230945A1 (hr) |
| BR (1) | BR112021017005A2 (hr) |
| CA (1) | CA3130899A1 (hr) |
| CL (1) | CL2021002237A1 (hr) |
| DK (1) | DK3930663T3 (hr) |
| EA (1) | EA202192391A1 (hr) |
| ES (1) | ES2932551T3 (hr) |
| FI (1) | FI3930663T3 (hr) |
| GE (1) | GEP20237472B (hr) |
| HR (1) | HRP20221439T1 (hr) |
| HU (1) | HUE061087T2 (hr) |
| IL (1) | IL285497B1 (hr) |
| IT (1) | IT201900003009A1 (hr) |
| JO (1) | JOP20210210A1 (hr) |
| LT (1) | LT3930663T (hr) |
| MA (1) | MA55078B1 (hr) |
| MD (1) | MD3930663T2 (hr) |
| PL (1) | PL3930663T3 (hr) |
| PT (1) | PT3930663T (hr) |
| RS (1) | RS63853B1 (hr) |
| SG (1) | SG11202108777SA (hr) |
| SI (1) | SI3930663T1 (hr) |
| TW (1) | TW202100133A (hr) |
| UA (1) | UA127726C2 (hr) |
| UY (1) | UY38598A (hr) |
| WO (1) | WO2020178148A1 (hr) |
| ZA (1) | ZA202107399B (hr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230250490A1 (en) * | 2022-02-10 | 2023-08-10 | Colgate-Palmolive Company | Microbially Induced Inflammation Produces Changes in Distinct Healthy Tissues in Human Oral Cavity |
| IT202200003869A1 (it) * | 2022-03-02 | 2023-09-02 | Restituta Castellaccio | Prodotto per l’igiene orale |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0558866A (ja) * | 1991-08-28 | 1993-03-09 | Lion Corp | 口腔用組成物 |
| US5547684A (en) * | 1993-02-10 | 1996-08-20 | Pharmec Company | Cosmetic composition containing a DNA-sodium salt and methods of making and using the same |
| AU6584994A (en) * | 1993-05-24 | 1994-12-20 | Nauchno-Proizvodstvennoe Predpriyatie "Farmek" | Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
| ITMI20020421A1 (it) * | 2002-03-01 | 2003-09-01 | Restituita Castellaccio | Colluttorio per l'igiene orale a base di clorexidina |
| ITMI20120019A1 (it) * | 2012-01-10 | 2013-07-11 | Restituta Castellaccio | Colluttorio |
| LT3171854T (lt) * | 2015-05-08 | 2020-07-27 | Curasept Ads S.R.L. | Patobulintas burnos skalavimo skysčio preparatas |
| JP2018203628A (ja) * | 2017-05-30 | 2018-12-27 | 一丸ファルコス株式会社 | 化粧料組成物又は飲食品組成物 |
-
2019
- 2019-03-01 IT IT102019000003009A patent/IT201900003009A1/it unknown
-
2020
- 2020-02-27 MA MA55078A patent/MA55078B1/fr unknown
- 2020-02-27 HR HRP20221439TT patent/HRP20221439T1/hr unknown
- 2020-02-27 EP EP20711798.7A patent/EP3930663B1/en active Active
- 2020-02-27 CA CA3130899A patent/CA3130899A1/en active Pending
- 2020-02-27 US US17/435,314 patent/US20220117868A1/en active Pending
- 2020-02-27 RS RS20221098A patent/RS63853B1/sr unknown
- 2020-02-27 JO JOP/2021/0210A patent/JOP20210210A1/ar unknown
- 2020-02-27 IL IL285497A patent/IL285497B1/en unknown
- 2020-02-27 BR BR112021017005A patent/BR112021017005A2/pt unknown
- 2020-02-27 PT PT207117987T patent/PT3930663T/pt unknown
- 2020-02-27 SI SI202030127T patent/SI3930663T1/sl unknown
- 2020-02-27 SG SG11202108777SA patent/SG11202108777SA/en unknown
- 2020-02-27 KR KR1020217031315A patent/KR20220004962A/ko unknown
- 2020-02-27 CN CN202080016697.5A patent/CN113645941A/zh active Pending
- 2020-02-27 EA EA202192391A patent/EA202192391A1/ru unknown
- 2020-02-27 UA UAA202104969A patent/UA127726C2/uk unknown
- 2020-02-27 AU AU2020230945A patent/AU2020230945A1/en active Pending
- 2020-02-27 FI FIEP20711798.7T patent/FI3930663T3/fi active
- 2020-02-27 TW TW109106472A patent/TW202100133A/zh unknown
- 2020-02-27 DK DK20711798.7T patent/DK3930663T3/da active
- 2020-02-27 HU HUE20711798A patent/HUE061087T2/hu unknown
- 2020-02-27 PL PL20711798.7T patent/PL3930663T3/pl unknown
- 2020-02-27 LT LTEPPCT/EP2020/055199T patent/LT3930663T/lt unknown
- 2020-02-27 MD MDE20220011T patent/MD3930663T2/ro unknown
- 2020-02-27 ES ES20711798T patent/ES2932551T3/es active Active
- 2020-02-27 WO PCT/EP2020/055199 patent/WO2020178148A1/en active Search and Examination
- 2020-02-27 GE GEAP202015745A patent/GEP20237472B/en unknown
- 2020-02-28 UY UY0001038598A patent/UY38598A/es unknown
- 2020-02-28 AR ARP200100559A patent/AR118218A1/es unknown
-
2021
- 2021-08-24 CL CL2021002237A patent/CL2021002237A1/es unknown
- 2021-09-30 ZA ZA2021/07399A patent/ZA202107399B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20221439T1 (hr) | Proizvod za oralnu njegu | |
| Bascones Martínez et al. | Las enfermedades periodontales como infecciones bacterianas | |
| Kraivaphan et al. | Two-year caries clinical study of the efficacy of novel dentifrices containing 1.5% arginine, an insoluble calcium compound and 1,450 ppm fluoride | |
| ES2795356T3 (es) | Preparación de colutorios mejorados | |
| RU2018105785A (ru) | Композиции для ухода за полостью рта и способы их применения | |
| RU2015123679A (ru) | Продукты для ухода за полостью рта, содержащие комплекс четырехосновной цинк-аминокислота-галогенид | |
| AR076179A1 (es) | Composicion dentifrica no acuosa con vidrio bioaceptable y bioactivo y metodos de uso y fabricacion de la misma | |
| RU2013111534A (ru) | Средство для ухода за полостью рта, способы его применения и производства | |
| RU2018144600A (ru) | Композиции для ухода за полостью рта | |
| US8475773B2 (en) | Oral hygiene method and formula | |
| US9867892B2 (en) | Aqueous cleanser for dental appliances | |
| RU2013126518A (ru) | Продукт для ухода за полостью рта и способы его применения и изготовления | |
| JP2015500336A5 (hr) | ||
| RU2017135563A (ru) | Композиции для ухода за полостью рта | |
| Seriwatanachai et al. | Effect of stannous fluoride and zinc phosphate dentifrice on dental plaque and gingivitis: A randomized clinical trial with 6-month follow-up | |
| CN105310960A (zh) | 一种新型多糖抗菌漱口液及其制备方法 | |
| CN113842337A (zh) | 一种口感优良的抑菌组合物及其应用 | |
| CN107007538B (zh) | 一种含海洋元素的口腔护理组合物和应用，及含海洋元素的牙膏 | |
| RU2010145035A (ru) | Минерально-витаминный комплекс для укрепления эмали зубов, композиция для гигиены полости рта и зубная паста | |
| ES2290673T3 (es) | Composicion para el tratamiento de la cavidad bucal y utilizaciones correspondientes. | |
| White et al. | In vivo antiplaque efficacy of combined antimicrobial dentifrice and rinse hygiene regimens. | |
| JP7499005B2 (ja) | 歯肉の活性化剤 | |
| Gupta et al. | An In-vitro analysis of the staining effect of different chemical mouthwashes | |
| Kaufman et al. | A Comparison Study Between Chlorhexidine and Bisdequalinium Acetate in Solution and Lozenge Form as a Plaque-Preventing Agent. | |
| Obersztyn et al. | Effects of stannous fluoride and amine fluorides on caries incidence and enamel solubility in adults |